Company intelligence / Profile preview
Medexus Pharmaceuticals
Toronto, Ontario, Canadamedexus.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Commercial
01
Overview
Medexus Pharmaceuticals operates a fully integrated specialty pharma business with a focus on rare diseases and specialty therapeutics. Its portfolio includes commercialized products such as Rasuvo/Metoject for autoimmune diseases, IXINITY for hemophilia B, Rupall for allergies, Trecondyv/Treosulfan as a conditioning agent prior to stem cell transplantation. The company reported record revenue of $113.1 million in fiscal year 2024 and anticipates significant growth pending US approval of treosulfan. Clinical programs include label expansion studies such as Phase IV trials for IXINITY in pediatric hemophilia B patients.
- Therapeutic areas
- OncologyDermatologyImmunologyHematology
- Modalities
- Small moleculesrecombinant proteins (e.g., recombinant coagulation factors)cytotoxic drugs
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Licensing partnerships with medac GmbH (for treosulfan) and previous partnership with NX Development Corp. regarding Gleolan®
Beyond the preview
Go deeper on Medexus Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medexus Pharmaceuticals.